Bora Pharmaceuticals, a contract development and manufacturing organization (CDMO) that specializes in complex modified release (MR) products and solvent production, has announced the opening of its first North American office in Delaware.   The Asia-Pacific (APAC)-headquartered CDMO, which has invested over $60 million in acquiring world class facilities in recent years, has established the office as part of its two-year plan to invest in the North American market.   “Opening an office on the E...